GLUE · Monte Rosa Therapeutics, Inc.
Market Cap
$1.14B
Shares
85.31M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2022-07 | 2025-03-20 | $100,000,000 | — | — | 10-K , filed 2026-03-17 |
Key facts
CIK
1826457
CUSIP
61225M102
13F (30d)
176 filings
173 filers
Visit website
Investor relations